Clinical Trial Update: Study of Sacituzumab Govitecan With Atezolizumab/Durvalumab as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating sacituzumab govitecan with atezolizumab and durvalumab as maintenance therapy for extensive-stage small cell lung cancer; recruitment i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer
• Small Cell Lung Cancer

Drugs mentioned

• Imfinzi (durvalumab) (durvalumab)
• Tecentriq (atezolizumab) (atezolizumab)
• Trodelvy (sacituzumab govitecan) (sacituzumab govitecan)

Snippet

Sponsor: Bindu R Potugari | Conditions: Small Cell Lung Cancer ( SCLC ), Extensive Stage Small Cell Lung Cancer (ES-SCLC) | Phase 2 | Status: RECRUITING